GB1287433A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB1287433A
GB1287433A GB39610/69A GB3961069A GB1287433A GB 1287433 A GB1287433 A GB 1287433A GB 39610/69 A GB39610/69 A GB 39610/69A GB 3961069 A GB3961069 A GB 3961069A GB 1287433 A GB1287433 A GB 1287433A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutically acceptable
acceptable salt
acetylsalicylic acid
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB39610/69A
Inventor
David Maxwell Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE754602D priority Critical patent/BE754602A/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Priority to GB39610/69A priority patent/GB1287433A/en
Priority to IE920/70A priority patent/IE34386B1/en
Priority to ZA704998A priority patent/ZA704998B/en
Priority to NL7011044A priority patent/NL7011044A/xx
Priority to LU61447D priority patent/LU61447A1/xx
Priority to FR707028612A priority patent/FR2068470B1/fr
Priority to ES382438A priority patent/ES382438A1/en
Priority to DE19702038792 priority patent/DE2038792A1/en
Priority to AT711970A priority patent/AT297921B/en
Publication of GB1287433A publication Critical patent/GB1287433A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/618Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate

Abstract

1287433 Composition comprising acetylsalicylic acid BEECHAM GROUP Ltd 20 July 1970 [7 Aug 1969] 39610/69 Heading A5B A pharmaceutical composition contains as active ingredients acetylsalicylic acid or a pharmaceutically acceptable salt thereof and 4-chlorophenoxyacetic acid 2,2-diethylaminoethylamide or a pharmaceutically acceptable salt thereof.
GB39610/69A 1969-08-07 1969-08-07 Pharmaceutical compositions Expired GB1287433A (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
BE754602D BE754602A (en) 1969-08-07 CLOFEXAMIDE AND ASPIRINE TO REDUCE GASTRIC IRRITATION
GB39610/69A GB1287433A (en) 1969-08-07 1969-08-07 Pharmaceutical compositions
IE920/70A IE34386B1 (en) 1969-08-07 1970-07-15 Pharmaceutical compositions
ZA704998A ZA704998B (en) 1969-08-07 1970-07-21 Pharmaceutical compositions
NL7011044A NL7011044A (en) 1969-08-07 1970-07-24
LU61447D LU61447A1 (en) 1969-08-07 1970-07-30
FR707028612A FR2068470B1 (en) 1969-08-07 1970-08-03
ES382438A ES382438A1 (en) 1969-08-07 1970-08-04 Pharmaceutical compositions
DE19702038792 DE2038792A1 (en) 1969-08-07 1970-08-04 Orally applicable medicinal preparation containing a salicylic acid derivative with better gastric tolerance
AT711970A AT297921B (en) 1969-08-07 1970-08-05 Process for the preparation of pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB39610/69A GB1287433A (en) 1969-08-07 1969-08-07 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB1287433A true GB1287433A (en) 1972-08-31

Family

ID=10410502

Family Applications (1)

Application Number Title Priority Date Filing Date
GB39610/69A Expired GB1287433A (en) 1969-08-07 1969-08-07 Pharmaceutical compositions

Country Status (10)

Country Link
AT (1) AT297921B (en)
BE (1) BE754602A (en)
DE (1) DE2038792A1 (en)
ES (1) ES382438A1 (en)
FR (1) FR2068470B1 (en)
GB (1) GB1287433A (en)
IE (1) IE34386B1 (en)
LU (1) LU61447A1 (en)
NL (1) NL7011044A (en)
ZA (1) ZA704998B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668245A (en) * 1986-10-22 1987-05-26 Bankamerica Corporation Fuel additive for use in alcohol fuels
WO2018231795A1 (en) * 2017-06-13 2018-12-20 Afecta Pharmaceuticals, Inc. Ccl2 inhibitors

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668245A (en) * 1986-10-22 1987-05-26 Bankamerica Corporation Fuel additive for use in alcohol fuels
WO2018231795A1 (en) * 2017-06-13 2018-12-20 Afecta Pharmaceuticals, Inc. Ccl2 inhibitors
US11130729B2 (en) 2017-06-13 2021-09-28 Lapko Inc. CCL2 inhibitors
US11858876B2 (en) 2017-06-13 2024-01-02 Lapko Inc. CCL2 inhibitors

Also Published As

Publication number Publication date
ES382438A1 (en) 1973-04-16
NL7011044A (en) 1971-02-09
BE754602A (en) 1971-02-08
FR2068470A1 (en) 1971-08-27
LU61447A1 (en) 1970-10-05
DE2038792A1 (en) 1971-02-18
IE34386L (en) 1971-02-07
IE34386B1 (en) 1975-04-30
AT297921B (en) 1972-04-10
ZA704998B (en) 1971-04-28
FR2068470B1 (en) 1974-02-22

Similar Documents

Publication Publication Date Title
AU8251275A (en) Pharmaceutical compositions comprising 6,8-diethyl-5-hydroxy-4-oxo-4h-1-benzopyran-2-carboxylic acid, and their uses
GB1403900A (en) Pharmaceutical composition
GB1202148A (en) Pharmaceutical compositions
GB1287433A (en) Pharmaceutical compositions
CA961041A (en) 1-methyl-3-alkoxymethyl-5,5-disub-stituted barbituric acid compounds and therapeutic compositions containing same
GB1261989A (en) 5-thiazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing the same
GB1482651A (en) Pharmaceutical products
CA1008461A (en) 3,4-dihydroxyphenyl-alamines as active ingredients of antioxidant compositions
GB1187546A (en) Propanolamine derivatives
GB1321466A (en) N-acetyl-6-amino-hexanoic acid derivative process for its production and pharmaceutical compositions containing the derivative
GB1299037A (en) Dithiocarbamic acid esters
GB1261454A (en) Improved analgesic systems and compositions
GB1193438A (en) Barbituric Acid Derivatives, preparation thereof and Pharmaceutical Compositions containing them
CA820860A (en) Pharmaceutical composition containing the hydrochloric acid addition salt of 2-amino-adamantane as active ingredient
CA953715A (en) N(6)-(2,5-dimethylbenzyl)-2-chloroadenosine derivatives, process for their preparation and pharmaceutical compositions containing the same
GB1509778A (en) Pharmaceutical composition and dosage units thereof
AU456249B2 (en) Pharmaceutical compositions containing 4 hydroxynicotinic acid
CA945544A (en) 16-METHYLENE-9.beta., 10.alpha.-STEROID COMPOUNDS, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN THE NOVEL COMPOUNDS AS ACTIVE INGREDIENTS, AND METHODS OF PRODUCING THE SAID COMPOUNDSAND PREPARATIONS
CA946374A (en) 17.beta.-HYDROXY-17.alpha.-(2'-METHALLYL)9.beta.,10.alpha.-ANDROSTA-1,4,6-TRIEN-3-ONE, METHODS OF PRODUCING THIS COMPOUND AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUND AS AN ACTIVE INGREDIENT
GB1454872A (en) Anticonvulsant
CA1019765A (en) Salts of 2,6-dioxocyclohexane thiocarboxylic acid 4'-halo-anilides and pharmaceutical compositions thereof
CA804582A (en) PHARMACEUTICAL PREPARATIONS CONTAINING .alpha.-AMINO-.beta.-(3:4-DICHLOROPHENYL)-BUTYRIC ACID, OR ITS SALTS
AU289517B2 (en) Pharmaceutical compositions containing 2,4,6 trihydroxy benzonic acid and its salts
CA957373A (en) Salts of para-chlorophenoxyisobutyric acid, their preparation and pharmaceutical compositions containing them
GB1254125A (en) Pharmaceutical composition suitable for the treatment of certain vascular diseases

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees